Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Ann Surg Oncol. 2019 Apr 4;27(1):196–202. doi: 10.1245/s10434-019-07333-8

FIG. 1.

FIG. 1

a Recurrence-free survival and b overall survival (in months) following pelvic lymph node dissection, stratified by operative approach (open vs. robotic-assisted). There was no significant difference in either recurrence free or overall survival between operative approaches to metastatic disease in the pelvic lymph nodes